Véronique Lauzon

Principal Health Economist

Véronique brings over 20 years of expertise in the pharmacoeconomic industry, with a master’s degree in economics and a specialization in health economic evaluations. She is proficient in conducting cost-effectiveness analyses, budget impact modeling, and outcomes research, with a particular focus on orphan products for rare diseases.
Her work has contributed to securing positive reimbursement recommendations from agencies such as CDA, PBAC, and NICE. Véronique is highly skilled at developing innovative de novo models for first-in-class therapies and refining existing models to meet the needs of local markets. Additionally, she has extensive experience analyzing clinical trial and real-world data to generate impactful evidence for market access.
Passionate about improving healthcare access, Véronique approaches each project with dedication and precision. Her collaborative style and strategic insights enable clients to navigate complex reimbursement processes successfully, ensuring life-saving therapies reach the patients who need them.